2548 results found
Welcome to Tracker, NHMRC’s fortnightly newsletter with the latest information on major activities and funding opportunities
Associate Professor Antony Cooper from the Garvan Institute of Medical Research is a cell and molecular biologist / geneticist with strong interests in elucidating how cellular dysfunction results in human diseases, with a specific interest in neurodegenerative disease such as Parkinson’s Disease. His research on neurodegenerative diseases focuses on understanding the basis of Parkinson’s Disease. Watch his story in the video below.
The National Health and Medical Research Council (NHMRC) engages with health consumer and community groups to identify community representatives, consumers and/or carers to participate in our committees, peer review processes, guideline development and public consultation.
Sapphire is NHMRC's solution for supporting end-to-end management of all Medical Research Endowment Account (MREA) grant opportunities (GOs) as well as Medical Research Future Fund (MRFF) GOs administered by NHMRC on behalf of the Department of Health and Aged Care.
Developing better understanding of effective therapeutic practices with Aboriginal clients, in Aboriginal community settings, and with Aboriginal practitioners, across the spectrum of mental health and social and emotional wellbeing outcomes is the goal of Dr Graham Gee.
The eighth meeting of the National Health and Medical Research Council’s (NHMRC) Dietary Guidelines Expert Committee (Expert Committee) was held in April via videoconference.
This document clarifies the responsibilities of those involved in clinical trials to monitor and report adverse events and other safety issues. Supplementary guidance on other clinical trial safety monitoring and reporting issues is also available*.
The Peer Review Analysis Committee was established on 1 October 2020 under section 39 of the National Health and Medical Research Council Act 1992, to advise the NHMRC CEO on aspects of the peer review process.
Genetic tests are easily purchased by consumers, often over the internet and usually without the involvement of a medical professional. These tests can be used in diagnosing medical conditions or pre-dispositions. The statement highlights issues for medical professionals and consumers regarding the use of health-related genetic testing.
There are concerns about the increasing availability of health-related genetic testing kits. This guide is for health professionals whose patients are considering buying a test kit or want to discuss their results.
DNA testing can be used for a number of purposes not related to health. One area of interest is the potential for DNA testing and genetic profiles in sport applications such as talent identification, individualised training programs and avoidance of sport-related injury.
Peer Reviewer Comments Disclaimer for NHMRC schemes that provide qualitative feedback.
As the Australian Government's lead agency for funding health and medical research, the National Health and Medical Research Council (NHMRC) is committed to achieving gender equity in its grant program.
The introduction of structural priority funding in 2017 has significantly reduced disparities between women and men in the number of grants and total funding awarded.
At the request of the Minister for Health and Aged Care, the National Health and Medical Research Council has undertaken a review of gain-of-function research in Australia. The Executive Summary from the review report, and a copy of the full report, is available below.
Purpose The purpose of this statement is to clarify the expectations of the National Health and Medical Research Council (NHMRC) with respect to the use of smoke inhalation procedures in rodents in NHMRC-funded research. It can also be used by those involved with, or considering, the use of smoke inhalation procedures in rodents in research funded from other sources.